Abstract

As the fourth industrial revolution approaches, the technological revolution has a tangible impact on every production sector. In this new environment, three-dimensional (3D) printing has already demonstrated its promise with impressive uses in the creation of medicine delivery systems. Global research efforts have been focused on the notion of personalising the dosage form through better formulation functions or individualised medicinal doses. To encourage the real-time manufacture of pharmaceutical goods in dispersed locations, important elements that go beyond the manufacturing level must be taken into account. The majority of current research efforts are devoted to developing 3D-printed medicine delivery systems and illustrating various installation possibilities for 3D printers in the pharmaceutical, community, and hospital sectors as well as in patients’ homes. A wide range of factors are presented by this research that need to be taken into account in order to incorporate 3D printing into a future healthcare system. Of particular importance are regulatory concerns, drug shortages, product quality assurance, and the public’s and healthcare professionals’ acceptance of these scenarios. This review’s goal is to critically show the range of possibilities that might lead to the use of 3D printing in healthcare in the future and to talk about the concerns that will inevitably come up